Fernando
Aranda Vega
Investigador Colaborador
Publikationen (78) Publikationen von Fernando Aranda Vega
2024
-
Animal models of disease: Achievements and challenges
Methods in Cell Biology
-
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C
Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4
-
Peritoneal carcinomatosis in mouse models
Methods in Cell Biology (Academic Press Inc.), pp. 67-78
-
Preface
Methods in Cell Biology
-
Tumor slice culture system for ex vivo immunotherapy studies
Methods in Cell Biology, Vol. 189, pp. 55-69
-
Unveiling the multifaceted antitumor effects of interleukin 33
Frontiers in Immunology
2023
-
Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8+ T cells eradicates peritoneal metastases in mouse models
Oncoimmunology, Vol. 12, Núm. 1, pp. 2147317
-
Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis
Journal for immunotherapy of cancer, Vol. 11, Núm. 11
-
Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure
Molecular Therapy - Nucleic Acids, Vol. 33, pp. 599-616
-
The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosis
OncoImmunology
2022
-
CD6 deficiency impairs early immune response to bacterial sepsis
iScience, Vol. 25, Núm. 10
-
Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution
Prostate, Vol. 82, Núm. 14, pp. 1331-1337
-
Novel strategies exploiting interleukin-12 in cancer immunotherapy
Pharmacology and Therapeutics, Vol. 239
-
Omentum: Friend or foe in ovarian cancer immunotherapy?
International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 117-131
-
Overcoming the limitations of cytokines to improve cancer therapy
International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 107-141
-
Revisiting Intracavitary Immunotherapy of Cancer
Clinical Cancer Research, Vol. 28, Núm. 10, pp. 1993-1995
-
Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis
OncoImmunology, Vol. 11, Núm. 1
2021
-
Firefighters for the wrong type of inflammation in tumors
Cancer Discovery, Vol. 11, Núm. 10, pp. 2372-2374
-
Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 11
-
Mouse models of peritoneal carcinomatosis to develop clinical applications
Cancers, Vol. 13, Núm. 5, pp. 1-11